These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 112635)

  • 1. Interaction between delta 9-tetrahydrocannabinol and morphine on the motor activity of mice.
    Ayhan IH; Kaymakçalan S; Tulunay FC
    Psychopharmacology (Berl); 1979 May; 63(2):169-72. PubMed ID: 112635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of delta 9-tetrahydrocannabinol on the morphine-induced hyperactivity of mice.
    Ulkü E; Ayhan IH; Tulunay FC; Uran B; Kaymakçalan S
    Psychopharmacology (Berl); 1980; 69(2):201-5. PubMed ID: 6256790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of morphine and delta-9-tetrahydrocannabinol on motor activity in rats.
    Tulunay FC; Ayhan IH; Sparber SB
    Psychopharmacology (Berl); 1982; 78(4):358-60. PubMed ID: 6296906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-tolerance to the hypothermic effect of delta 8-tetrahydrocannabinol 11-hydroxy-delta 8-tetrahydrocannabinol and chlorpromazine in the mouse.
    Yamamoto I; Watanabe K; Narimatsu S; Hamajima K; Yoshimura H
    Eur J Pharmacol; 1985 May; 111(2):159-66. PubMed ID: 2990949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delta-9-tetrahydrocannabinol differentially suppresses cisplatin-induced emesis and indices of motor function via cannabinoid CB(1) receptors in the least shrew.
    Darmani NA
    Pharmacol Biochem Behav; 2001; 69(1-2):239-49. PubMed ID: 11420092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biphasic effects of Δ9-tetrahydrocannabinol on brain stimulation reward and motor activity.
    Katsidoni V; Kastellakis A; Panagis G
    Int J Neuropsychopharmacol; 2013 Nov; 16(10):2273-84. PubMed ID: 23830148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolerance to the reinforcing effects of morphine in delta9-tetrahydrocannabinol treated mice.
    Jardinaud F; Roques BP; Noble F
    Behav Brain Res; 2006 Oct; 173(2):255-61. PubMed ID: 16884789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conditioned place preference induced by delta 9-tetrahydrocannabinol: comparison with cocaine, morphine, and food reward.
    Lepore M; Vorel SR; Lowinson J; Gardner EL
    Life Sci; 1995; 56(23-24):2073-80. PubMed ID: 7776834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulant actions of delta9-tetrahydrocannabinol in mice.
    Evans MA; Harbison RD; Brown DJ; Forney RB
    Psychopharmacology (Berl); 1976 Nov; 50(3):245-50. PubMed ID: 826969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of perinatal exposure to delta 9-tetrahydrocannabinol on operant morphine-reinforced behavior.
    González B; de Miguel R; Martín S; Pérez-Rosado A; Romero J; García-Lecumberri C; Fernández-Ruiz J; Ramos JA; Ambrosio E
    Pharmacol Biochem Behav; 2003 Jun; 75(3):577-84. PubMed ID: 12895675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A vapourized Δ(9)-tetrahydrocannabinol (Δ(9)-THC) delivery system part II: comparison of behavioural effects of pulmonary versus parenteral cannabinoid exposure in rodents.
    Manwell LA; Ford B; Matthews BA; Heipel H; Mallet PE
    J Pharmacol Toxicol Methods; 2014; 70(1):112-9. PubMed ID: 24956154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of some pharmacological actions of morphine and delta9-tetrahydrocannabinol in the mouse.
    Bloom AS; Dewey WL
    Psychopharmacology (Berl); 1978 May; 57(3):243-8. PubMed ID: 97703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of cannabinoids on intestinal motility and their antinociceptive effect in mice.
    Chesher GB; Dahl CJ; Everingham M; Jackson DM; Marchant-Williams H; Starmer GA
    Br J Pharmacol; 1973 Dec; 49(4):588-94. PubMed ID: 4788032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary and systemic hemodynamic effects of delta9-tetrahydrocannabinol in conscious and morphine--chloralose-anesthetized dogs: anesthetic influence on drug action.
    Jandhyala BS; Hamed AT
    Eur J Pharmacol; 1978 Dec; 53(1):63-8. PubMed ID: 738360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurobehavioral actions of cannabichromene and interactions with delta 9-tetrahydrocannabinol.
    Davis WM; Hatoum NS
    Gen Pharmacol; 1983; 14(2):247-52. PubMed ID: 6301931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-exposure effects of morphine, diazepam and delta 9-THC on the formation of conditioned taste aversions.
    Switzman L; Fishman B; Amit Z
    Psychopharmacology (Berl); 1981; 74(2):149-57. PubMed ID: 6267645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of SR 141716A-induced head-twitch and ear-scratch responses in mice by delta 9-THC and other cannabinoids.
    Janoyan JJ; Crim JL; Darmani NA
    Pharmacol Biochem Behav; 2002; 71(1-2):155-62. PubMed ID: 11812518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of THC, nantradol, nabilone, and morphine in the chronic spinal dog.
    Gilbert PE
    J Clin Pharmacol; 1981; 21(S1):311S-319S. PubMed ID: 6271835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex differences in cannabinoid 1 vs. cannabinoid 2 receptor-selective antagonism of antinociception produced by delta9-tetrahydrocannabinol and CP55,940 in the rat.
    Craft RM; Wakley AA; Tsutsui KT; Laggart JD
    J Pharmacol Exp Ther; 2012 Mar; 340(3):787-800. PubMed ID: 22182934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex-dependent effects of delta 9-tetrahydrocannabinol on locomotor activity in mice.
    Wiley JL
    Neurosci Lett; 2003 Dec; 352(2):77-80. PubMed ID: 14625027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.